Stragen is an international pharmaceutical group specialized in the development, manufacturing, and commercialization of specialty medicines. Operating across multiple countries, Stragen combines an entrepreneurial culture with strong governance, quality standards, and regulatory compliance in a highly regulated environment.Business Development Manager:Reporting to the Chief Commercial & Business Development OfficerGeographic scope: GlobalThe Business Development Manager will support and assist the CC&BDO in BD global opportunities’ coordination (both internal and external). Assist and deputize, when necessary, with contract’s negotiation, BD forums, scouting activities, company meetings.BDM will interact with internal corporate departments (Medico Marketing/CI/Regulatory/Supply Chain/Finance, etc.) and global commercial teams’ representatives (Country Managers, B2B Partners, etc.)Main areas of focus and activities:Scouting and Identifying BD opportunities, with an In-Licensing and Co-Marketing focus, within the expanding perimeter of Stragen’s commercialisation strategy. Work with Portfolio development, for maintenance and coordination of databases for BD&L and interdepartmental strategic initiatives/projects. These can include, BD projects, Therapy Areas/Segments, Strategic Pillars, Competitors mapping, Development companies/projectsEnsure appropriate and timely engagement with all critical steps within then BD value chain; These include, CDAs, Initial Terms, IQVIA/CI data coordination, Business Plans’ coordination, Due Diligence Data room coordination (both internal/external)Assist and deputize the CC&BDO when necessary, in Conferences/BD forums/3rd party Company discussions and follow up actions.Hands on collaboration with corporate departments for BD development projectsProactive follow up, with COO and Finance, to ensure the availability of Commercial Business cases both from a timely and qualitative perspectiveEnsure appropriate follow up and alignment of activities, with predefined departmental and corporate prioritiesAssist with the department’s budget preparation, monthly reporting requirements.RequirementsMaster degree in Business or equivalentExperience in licensing, business development or merger & acquisition project coordinationInternational experience with preference in pharmaceutical/health sectorExposure and good understanding of business and financial casesLarge autonomy, dynamism, “problem solving”, mixing entrepreneurial and team player mindsetOperate within a lean organisationTeam Player, humble attitude, adaptiveExcellent communication, presentation skills and organizational skillsAbility to manage multiple projects and stakeholdersEnglish fluent mandatory, French as a plusThere could be local and regional Business trips (up to 20%). The presence at HQ is needed, percentage to be discussed. Contract to be established in France.
Stragen is an international pharmaceutical group specialized in the development, manufacturing, and commercialization of specialty medicines. Operating across multiple countries, Stragen combines an entrepreneurial culture with strong governance, quality standards, and regulatory compliance in a highly regulated environment.
Business Development Manager:
Reporting to the Chief Commercial & Business Development Officer
Geographic scope: Global
The Business Development Manager will support and assist the CC&BDO in BD global opportunities’ coordination (both internal and external). Assist and deputize, when necessary, with contract’s negotiation, BD forums, scouting activities, company meetings.
BDM will interact with internal corporate departments (Medico Marketing/CI/Regulatory/Supply Chain/Finance, etc.) and global commercial teams’ representatives (Country Managers, B2B Partners, etc.)
Main areas of focus and activities:
- Scouting and Identifying BD opportunities, with an In-Licensing and Co-Marketing focus, within the expanding perimeter of Stragen’s commercialisation strategy.
- Work with Portfolio development, for maintenance and coordination of databases for BD&L and interdepartmental strategic initiatives/projects. These can include, BD projects, Therapy Areas/Segments, Strategic Pillars, Competitors mapping, Development companies/projects
- Ensure appropriate and timely engagement with all critical steps within then BD value chain; These include, CDAs, Initial Terms, IQVIA/CI data coordination, Business Plans’ coordination, Due Diligence Data room coordination (both internal/external)
- Assist and deputize the CC&BDO when necessary, in Conferences/BD forums/3rd party Company discussions and follow up actions.
- Hands on collaboration with corporate departments for BD development projects
- Proactive follow up, with COO and Finance, to ensure the availability of Commercial Business cases both from a timely and qualitative perspective
- Ensure appropriate follow up and alignment of activities, with predefined departmental and corporate priorities
- Assist with the department’s budget preparation, monthly reporting requirements.
Requirements
- Master degree in Business or equivalent
- Experience in licensing, business development or merger & acquisition project coordination
- International experience with preference in pharmaceutical/health sector
- Exposure and good understanding of business and financial cases
- Large autonomy, dynamism, “problem solving”, mixing entrepreneurial and team player mindset
- Operate within a lean organisation
- Team Player, humble attitude, adaptive
- Excellent communication, presentation skills and organizational skills
- Ability to manage multiple projects and stakeholders
- English fluent mandatory, French as a plus
There could be local and regional Business trips (up to 20%). The presence at HQ is needed, percentage to be discussed. Contract to be established in France.
With offices in the US, Europe and Asia, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to North American and European healthcare businesses.Prioritized areas of focus include Healthcare IT, MedTech, Pharma Services, Life Science Tools & Biologic Services, Biopharma Products, In Vitro Diagnostics, Consumer Health. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services.Over the last twenty years, ARCHIMED's leadership team has directly managed and invested in over eighty small to large-size healthcare companies globally, representing over €50 billion of combined value. ARCHIMED manages €8 billion across its various funds. Since inception, ARCHIMED has been a committed Impact Investor, both directly and through its EURÊKA Foundation.The Team
An international team (British, French, German, Italian, Polish...) with complementary education and experience in the investment, medical, scientific, strategic and operational sectors
Composed of alumni from: INSEAD, Berkeley, Georgetown, Bocconi, HEC Paris, Ponts et Chaussées, ESSEC, Imperial College, Dartmouth, etc
Professional backgrounds: Private Equity (3i, Siparex, USS Ltd, Barings, capiton), Consulting (A.T. Kearney, Bain, McKinsey), M&A (Lazard, EY, KPMG, PwC), Industry (Biotronik, Cerba, Pharmacy, Veterinary)
With offices in the US, Europe and Asia, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to North American and European healthcare businesses.
Prioritized areas of focus include Healthcare IT, MedTech, Pharma Services, Life Science Tools & Biologic Services, Biopharma Products, In Vitro Diagnostics, Consumer Health. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services.
Over the last twenty years, ARCHIMED's leadership team has directly managed and invested in over eighty small to large-size healthcare companies globally, representing over €50 billion of combined value. ARCHIMED manages €8 billion across its various funds. Since inception, ARCHIMED has been a committed Impact Investor, both directly and through its EURÊKA Foundation.
The Team
- An international team (British, French, German, Italian, Polish...) with complementary education and experience in the investment, medical, scientific, strategic and operational sectors
- Composed of alumni from: INSEAD, Berkeley, Georgetown, Bocconi, HEC Paris, Ponts et Chaussées, ESSEC, Imperial College, Dartmouth, etc
- Professional backgrounds: Private Equity (3i, Siparex, USS Ltd, Barings, capiton), Consulting (A.T. Kearney, Bain, McKinsey), M&A (Lazard, EY, KPMG, PwC), Industry (Biotronik, Cerba, Pharmacy, Veterinary)
